ID

19908

Descripción

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form s to be obtained in (Dose 1) week 0 and (Dose 6) week 20.

Palabras clave

  1. 30/1/17 30/1/17 -
Subido en

30 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300

Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300

Pharmacokinetics
Descripción

Pharmacokinetics

Alias
UMLS CUI-1
C0031327
1. Pre-infusion
Descripción

1. Pre-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C0585032
2. Immediately post-infusion
Descripción

2. Immediately post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
3. 2 hours +/- 15 minutes post-infusion
Descripción

3. 2 hours +/- 15 minutes post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C4035164
4. 24 hours +/- 1 hour post-infusion
Descripción

4. 24 hours +/- 1 hour post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C1442770
5. 1 week +/- 4 hours post-infusion
Descripción

5. 1 week +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C1547085
6. 2 weeks +/- 4 hours post-infusion
Descripción

6. 2 weeks +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230
7. 3 weeks +/- 4 hours post-infusion
Descripción

7. 3 weeks +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230
8. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
Descripción

8. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230
Pharmacodynamics (alpha4 Integrin Saturation)
Descripción

Pharmacodynamics (alpha4 Integrin Saturation)

Alias
UMLS CUI-1
C0851347
1. Pre-infusion
Descripción

1. Pre-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C0585032
2. 2 hours +/- 15 minutes post-infusion
Descripción

2. 2 hours +/- 15 minutes post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C4035164
3. 1 week +/- 4 hours post-infusion
Descripción

3. 1 week +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C1547085
4. 2 weeks +/- 4 hours post-infusion
Descripción

4. 2 weeks +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230
5. 3 weeks +/- 4 hours post-infusion
Descripción

5. 3 weeks +/- 4 hours post-infusion

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230
6. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
Descripción

6. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0021440
UMLS CUI [1,2]
C3272301
UMLS CUI [1,3]
C0439230

Similar models

Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Pharmacokinetics
C0031327 (UMLS CUI-1)
Item
1. Pre-infusion
integer
C0021440 (UMLS CUI [1,1])
C0585032 (UMLS CUI [1,2])
Code List
1. Pre-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
2. Immediately post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
Code List
2. Immediately post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
3. 2 hours +/- 15 minutes post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C4035164 (UMLS CUI [1,3])
Code List
3. 2 hours +/- 15 minutes post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
4. 24 hours +/- 1 hour post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
Code List
4. 24 hours +/- 1 hour post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
5. 1 week +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C1547085 (UMLS CUI [1,3])
Code List
5. 1 week +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
6. 2 weeks +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
6. 2 weeks +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
7. 3 weeks +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
7. 3 weeks +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
8. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
8. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item Group
Pharmacodynamics (alpha4 Integrin Saturation)
C0851347 (UMLS CUI-1)
Item
1. Pre-infusion
integer
C0021440 (UMLS CUI [1,1])
C0585032 (UMLS CUI [1,2])
Code List
1. Pre-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
2. 2 hours +/- 15 minutes post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C4035164 (UMLS CUI [1,3])
Code List
2. 2 hours +/- 15 minutes post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
3. 1 week +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C1547085 (UMLS CUI [1,3])
Code List
3. 1 week +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
4. 2 weeks +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
4. 2 weeks +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
5. 3 weeks +/- 4 hours post-infusion
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
5. 3 weeks +/- 4 hours post-infusion
CL Item
Sample Collected (1)
CL Item
No Sample (2)
Item
6. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
integer
C0021440 (UMLS CUI [1,1])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
Code List
6. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
CL Item
Sample Collected (1)
CL Item
No Sample (2)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial